Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Omega-3 fatty acids have been investigated for their potential role in supporting or treating diabetic retinopathy, a diabetes complication affecting the eyes. The rationale is primarily based on their anti-inflammatory properties and their role in maintaining retinal health. Several observational studies and animal experiments have suggested that higher dietary intake of omega-3 fatty acids, particularly from fish, may be associated with a reduced risk of developing diabetic retinopathy or slowing its progression. Mechanistically, omega-3s (notably EPA and DHA) may help modulate inflammation, reduce oxidative stress, and support vascular function in the retina.

However, the evidence from randomized controlled trials (RCTs) in humans is limited and not definitive. Some RCTs and meta-analyses report no significant benefit, while others indicate possible protective effects, especially in the context of a Mediterranean diet rich in omega-3s. Current clinical guidelines do not recommend omega-3 supplementation specifically for diabetic retinopathy due to insufficient high-quality evidence. Overall, while there is a scientific rationale and some supportive data from preclinical and observational research, robust clinical validation is lacking, resulting in a moderate evidence rating.

In summary, omega-3 is being studied for diabetic retinopathy due to plausible biological mechanisms and early research signals, but its use is not yet strongly supported by definitive clinical evidence.

More about Omega-3
More about Diabetic Retinopathy

Other ingredients used for Diabetic Retinopathy

Other health conditions supported by Omega-3

Products containing Omega-3